View Rule
View EO 12866 Meetings | Printer-Friendly Version Download RIN Data in XML |
DOD/DODOASHA | RIN: 0720-AB19 | Publication ID: Fall 2008 |
Title: TRICARE: Outpatient Hospital Prospective Payment System (OPPS) | |
Abstract: This rule implements a prospective payment system for hospital outpatient services similar to that furnished to Medicare beneficiaries, as set forth in section 1833(t) of the Social Security Act. The rule also recognizes applicable statutory requirements and changes arising from Medicares continuing experience with this system including certain related provisions of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003. | |
Agency: Department of Defense(DOD) | Priority: Other Significant |
RIN Status: Previously published in the Unified Agenda | Agenda Stage of Rulemaking: Final Rule Stage |
Major: No | Unfunded Mandates: No |
CFR Citation: 32 CFR 199 | |
Legal Authority: 5 USC 301 10 USC ch 55 |
Legal Deadline:
None |
||||||||||||
Statement of Need: This final rule implements the TRICARE Hospital Outpatient Prospective Payment System (OPPS) as mandated under section 707 of the National Defense Authorization Act of Fiscal Year 2002 (NDAA-02), Pub. L. 107-107 (December 28, 2001), changing the statutory authorization in 10 U.S.C. 1079(j)(2) to provide that TRICARE payment methods for institutional care be determined, to the extent practicable, in accordance with the same reimbursement rules used by Medicare. Under the above Congressional mandate, TRICARE will be paying for hospital outpatient services in accordance with the provisions outlined in section 1833(t) of the Social Security Act and its implementing Medicare regulation (42 CFR § 419). |
||||||||||||
Summary of the Legal Basis: There is a statutory basis for this final rule: Section 707 of the National Defense Authorization Act of Fiscal Year 2002 (NDAA-02), Pub. L. 107-107. |
||||||||||||
Alternatives: This is a statutory change; consequently, no alternatives were considered. |
||||||||||||
Anticipated Costs and Benefits: Anticipated costs of implementation are $20 million. Anticipated cost-savings for first full year of implementation are $80 - $90 million. |
||||||||||||
Risks: Failure to publish this final rule would result in noncompliance with a statutory provision--the NDAA-02/Public Law 107-107. |
||||||||||||
Timetable:
|
Regulatory Flexibility Analysis Required: No | Government Levels Affected: None |
Federalism: No | |
Included in the Regulatory Plan: Yes | |
RIN Data Printed in the FR: No | |
Agency Contact: David E. Bennett Department of Defense Office of Assistant Secretary for Health Affairs 1200 Defense Pentagon, Washington, DC 20301 Phone:303 676-3494 Email: david.bennett@tma.osd.mil |